At the pre-SIRT stage, the selected patient undergoes a catheter angiogram to scrutinize the arterial supply of the targeted tumor(s), followed by radionuclide mapping using Technetium-99m macroaggregated albumin (99mTc-MAA) [14]. This evidence concerns the gene ALB and neoplasm.